X

XyloCor Therapeutics, Inc.

18 employees

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

Basic info

Industry

research services

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2013

Funding rounds raised

Total raised

$23M

from 6 investors over 6 rounds

X

XyloCor Therapeutics, Inc. raised $23M on March 22, 2021

Investors: Sofinnova Ventures, Russia technology fund, EQT Life Sciences, Longwood Fund and Lumira Ventures

X

XyloCor Therapeutics, Inc. raised $17M on December 6, 2018

Investors: Sofinnova Ventures, Russia technology fund and EQT Life Sciences

FAQ